Drug
polyethylene glycol, ascorbic acid
polyethylene glycol, ascorbic acid is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_3
1
25%
Ph phase_4
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 42 (66.7%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
NCT05726097
completedphase_4
Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy
NCT02956057
completedphase_4
Comparison of Different Low Volume Solutions Prior to Colonoscopy
NCT03698474
unknown
Comparison of Low-volume PEG Plus Ascorbic Acid Versus Standard PEG Solution as Bowel Cleansing for Colonoscopy
NCT01740518
Clinical Trials (4)
Showing 4 of 4 trials
NCT05726097Phase 3
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
NCT02956057Phase 4
Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy
NCT03698474Phase 4
Comparison of Different Low Volume Solutions Prior to Colonoscopy
NCT01740518
Comparison of Low-volume PEG Plus Ascorbic Acid Versus Standard PEG Solution as Bowel Cleansing for Colonoscopy
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4